Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
Market Cap 96.73M P/E - EPS this Y 35.00% Ern Qtrly Grth -
Income -15.8M Forward P/E -2.08 EPS next Y -30.80% 50D Avg Chg -29.00%
Sales 8.41M PEG -0.11 EPS past 5Y - 200D Avg Chg -29.00%
Dividend N/A Price/Book 5.61 EPS next 5Y 15.00% 52W High Chg -64.00%
Recommedations 2.00 Quick Ratio 0.76 Shares Outstanding 31.04M 52W Low Chg 19.00%
Insider Own 5.79% ROA -39.70% Shares Float 29.72M Beta 1.14
Inst Own 24.39% ROE -299.88% Shares Shorted/Prior 1M/1.22M Price 3.52
Gross Margin -147.21% Profit Margin -187.84% Avg. Volume 214,420 Target Price -
Oper. Margin -156.79% Earnings Date Nov 11 Volume 205,497 Change -1.68%
About DURECT Corporation

DURECT Corporation, a biopharmaceutical company, develops medicines based on its epigenetic regulator program. The company's lead product larsucosterol (DUR-928), an endogenous, orally bioavailable small molecule that is in Phase IIb clinical trial to play a regulatory role in lipid metabolism, stress and inflammatory responses, and cell death and survival to treat alcohol-associated hepatitis, as well as completed Phase Ib clinical trial to treat patients with nonalcoholic steatohepatitis. It also offers ALZET product line that consists of osmotic pumps and accessories used for research in mice, rats, and other laboratory animals. In addition, the company offers POSIMIR, a post-surgical pain product to deliver bupivacaine over three days in adults; and Methydur to treat attention deficit hyperactivity disorder. It markets and sells its ALZET lines through direct sales force in the United States, as well as through a network of distributors in other countries. The company has strategic collaboration and other agreements with Virginia Commonwealth University Intellectual Property Foundation; Indivior UK Ltd.; and Innocoll Pharmaceuticals Limited. DURECT Corporation was incorporated in 1998 and is headquartered in Cupertino, California.

DURECT Corporation News
11/14/24 Q3 2024 DURECT Corp Earnings Call
11/14/24 Durect Corp (DRRX) Q3 2024 Earnings Call Highlights: Revenue Growth Amid Cost Reductions and ...
11/13/24 Durect (DRRX) Reports Q3 Loss, Misses Revenue Estimates
11/13/24 Durect: Q3 Earnings Snapshot
11/13/24 DURECT Corporation Reports Third Quarter 2024 Financial Results and Provides Business Update
11/06/24 DURECT Corporation to Announce Third Quarter 2024 Financial Results and Provide a Business Update
10/17/24 DURECT Corporation to Present Data on Larsucosterol at The Liver Meeting 2024
10/09/24 Durect Corp (DRRX) Q2 2024 Earnings Call Highlights: Revenue Growth and Strategic Advances Amid ...
09/25/24 DURECT Corporation Announces Phase 3 Registrational Trial Design for Larsucosterol in Alcohol-associated Hepatitis
09/04/24 DURECT Corporation to Present at the H.C. Wainwright Global Investment Conference
08/16/24 DURECT Second Quarter 2024 Earnings: EPS Beats Expectations, Revenues Lag
08/13/24 Durect (DRRX) Reports Q2 Loss, Lags Revenue Estimates
08/13/24 Durect: Q2 Earnings Snapshot
08/13/24 DURECT Corporation Reports Second Quarter 2024 Financial Results and Business Update
08/07/24 DURECT Corporation to Announce Second Quarter 2024 Financial Results and Provide a Business Update
06/19/24 Are Medical Stocks Lagging DURECT (DRRX) This Year?
07:00 AM DURECT Corporation Receives FDA Breakthrough Therapy Designation for Larsucosterol in Alcohol-Associated Hepatitis
05/14/24 Q1 2024 DURECT Corp Earnings Call
05/14/24 Durect Corp (DRRX) Q1 2024 Earnings Call Transcript Highlights: Navigating Financial Challenges ...
05/13/24 Durect (DRRX) Reports Q1 Loss, Misses Revenue Estimates
DRRX Chatroom

User Image Biomd12 Posted - 1 hour ago

$DRRX Whats the point of the conditional approval program if a drug like Larsucosterol doesn't qualify for AH? Did Jim even press the FDA on this or he just doesn't have the pull with the corrupt FDA?

User Image KINGSPARTAN Posted - 1 hour ago

$DRRX volume drying up. no interest, no funding, no parter, no buyout, no sense of urgency, lame and failed management team and BOD, shelved AH or tossed in the garbage drug = lower share price.

User Image KINGSPARTAN Posted - 1 hour ago

$DRRX Longs, @ld4 has already said it to, ”party is over”! Stock is down roughly 40% in last week and only up just over a measly 30% from a year ago. The company has been given the green light by the FDA months ago and they still cannot find a partner or any funding. What has this bunch of losers been doing? I’ll tell you…Nothing…and just drawing a huge paycheck out of the funds they have left. CEO and CFO are driving this down, possibly intentionally, and as a result I believe not getting a drug to market soon in order to save a number of lives. Shame on them.

User Image bigbulldaddy Posted - 23 hours ago

$DRRX I have to admit I’m a bit annoyed with the FDA here. They produced statistically significant reduction in mortality in the United States. Now to confirm the results they are being asked to literally produce the same results and just modify the trial success guidelines to match what they have already done. FDA just killed 50000 people by sandbagging this drug and asking them to reproduce statistical significance without a relevant change to the trial.

User Image chikadino1Twits Posted - 1 day ago

$DRRX will this stock moon if the company is acquired?

User Image chikadino1Twits Posted - 1 day ago

$DRRX still no funding?

User Image jim33 Posted - 1 day ago

$DRRX I wonder what longs are thinking with the stock descending below a buck again and no sign of reprieve from a partner, cut losses or ride it down hoping for a turnaround?

User Image chikadino1Twits Posted - 1 day ago

$DRRX didnt buffett buy this company?

User Image PharmaExpert Posted - 2 days ago

$AKBA, $APLS, $DRRX, $MCRB, $YTEN 🔥🔥🔥🔥🔥

User Image sawbone57 Posted - 3 days ago

$DRRX my one deep and abiding hope is that this board and officers stay awake at night with nightmares of the 80k worldwide deaths that occurred because of the delay in getting a deal done, rather than how to squeeze the last bit of financial juice out of this lemon for themselves. Patients first, shareholders second, employees third and board and officers last. That’s your mandate!!!

User Image MissBurns Posted - 3 days ago

$DRRX Where’s Brown now? In Cabo kicking back some Margaritas trying to figure out if he should go marlin fishing or play 9 holes of golf?

User Image sawbone57 Posted - 3 days ago

$DRRX looks like the rats have decided enough is enough, time to leave the sinking ship!

User Image Nethek Posted - 3 days ago

$DRRX What an other nice day!!! :D haha..

User Image putin2022 Posted - 3 days ago

$DRRX wonder what happened to that lady who shared screenshots of purchasing 2000-5000 shares a day of this?

User Image PenkeTrading Posted - 5 days ago

I found you an Oversold RSI (Relative Strength Index) on the daily chart of Durect Corporation. Is that bullish or bearish? $DRRX #Durect #RsiOversold #NASDAQ

User Image KINGSPARTAN Posted - 6 days ago

$DRRX Longs, it’s getting UGLY as others exit the building.

User Image KINGSPARTAN Posted - 6 days ago

$DRRX Longs, I truly believe that Brown, Papp, and team have not looked for a partner or even for a buyout. Papp was brought on to wind down operations financially. If the drug is as good as you Longs and Brown have claimed repeatedly then there is no reason a company, especially with deep pockets, would not look to partner and fund over $50-$100 Million to see this thru in exchange for 20-40% of revenue once on the market. Think about it, this amount of money upfront for upwards of $2 Billion per year??? This company has stunk for a long time and something still stinks.

User Image KINGSPARTAN Posted - 6 days ago

$DRRX @ld4 you damn right the ”party is over”!!!! in fact the party has been over for years. you and others did not want to listen and placed to much faith in this junkie, aka CEO. drug will be shelved or tossed in the garbage. Brown and team, already known for their failures, will go down as being the sole factor of the many lives lost to this horrible condition that could have been saved. this will tarnish their medical image and reputation forever! they had a chance to redeem their image and blew it.

User Image ld4 Posted - 6 days ago

$DRRX the party is over! That was the most uninspired call I have ever heard. Neither Brown or Papp could muster any energy. They had zero enthusiasm when talking about ”funding,” making it perfectly clear they have no hope they are getting any. An inexcusable waste of resources and a very promising treatment.

User Image KINGSPARTAN Posted - 6 days ago

$DRRX go Sparty, go Sparty, go go go….

User Image KINGSPARTAN Posted - 6 days ago

$DRRX dropping fast and no support. appears to be a six month low now. high volume today. seems like some are getting out. below $1 soon? delisting coming up? no partnerships or buyouts or nothing. Drug may get shelved to collect dust.

User Image Biomd12 Posted - 6 days ago

$DRRX Genuine question....Why can't they secure a partner? Why isn't there a bidding war? And better yet, why is the market basically saying this is worthless? Assuming even a 50% chance they can replicate US data, the company is claiming they need 50M to have a great shot at first to market for a blockbuster. How could any partner ask for a better risk/reward opportunity? There is no rational explanation. I'm now close to 100% convinced this doesn't add up, and something is massively off.

User Image bnjhnsn Posted - 6 days ago

$DRRX Riddle me this, which is a better situation to invest in? Company A: has an idea for a potential drug. They have enough cash on hand to reasonably get through a phase 1 and 2 trial. However, there is no data whatsoever to support a positive outcome upon trail completion. Company B: has the results of a phase 1 and 2 trial in possession. These results are very close to being significant enough to support a drug application. (90% probability of success). However, this company currently has no cash available to pay for the final trail. With no bias towards the company's management, which situation seems to offer better risk to reward?

User Image Drrxgernbcrx Posted - 1 week ago

$DRRX It looks like the next NIH grant funding tranch occurs February 5th. Could this be Durects ace in the hole?

User Image DMONEY1337 Posted - 1 week ago

$DRRX Everyone left here should call the company and demand answers. The lack of clarity around funding efforts is unacceptable. I'm now trying to contact members on the BoD. I've seen a lot of BS over the years, but this one might take the cake.

User Image Drrxgernbcrx Posted - 1 week ago

$DRRX It looks like the next tranch of NIH grant funding occurs February 5. Could this be the ace in the hole for Durect?

User Image KINGSPARTAN Posted - 1 week ago

$DRRX well, cannot say that I am surprised. did not even listen to the call but judging by the messages here, the press release, and the share price does not look good. Huge volume for the day so far. The share price closed yesterday below the 200 day MA and was already sitting below the 20 and 50 day MA. Not good. Say, what ever happened to the ”golden cross”? a close below $1.12 today would be the lowest close in six months back to May I believe. not good. having Posimir returned back not good. it appears to be worthless anyway. still no plan or start for a Phase III. money runs out next QTR most likely. CEO still in charge. spending much needed funds on useless conference and poster presentation coming up. better start washing cars. I see @sawbone57 still trying to put a positive spin on all this.

User Image brunoq14 Posted - 1 week ago

$DRRX $10.5M in cash. $10.5M in debt.

User Image johnnygogogo Posted - 1 week ago

$DRRX reverse merger w/ a private company that has cash is probably the best outcome for current shareholders. Change the name. JB retires, etc. And now Posmir boomeranging back (from the shelf), at least there’s something approved to market, hard to value though. Definitely odd that there was no ATM use and at the same time, they state runway of… less than 4 months?

User Image Biomd12 Posted - 1 week ago

$DRRX Something just has to be off here. Doesn't make sense. Idk if it has to do with the licensing arrangement with VCU or what but there is a reason they haven't partnered this yet. Maybe we will get clarity in the BK proceedings.

Analyst Ratings
HC Wainwright & Co. Neutral May 22, 24
HC Wainwright & Co. Neutral May 15, 24
Oppenheimer Outperform Apr 1, 24
HC Wainwright & Co. Neutral Mar 28, 24
JonesTrading Hold Nov 9, 23
HC Wainwright & Co. Neutral Nov 8, 23
Cantor Fitzgerald Overweight Aug 10, 23
HC Wainwright & Co. Buy Aug 10, 23
Cantor Fitzgerald Overweight May 17, 23
Insider Trades Relationship Date Transactions Cost($) #Shares Value($) #Share Own SEC Form 4
Robertson Judith J. Director Director Aug 18 Buy 0.85 80,943 68,801 356,132 08/22/22
Robertson Judith J. Director Director Aug 17 Buy 0.84 10,189 8,559 275,189 08/19/22
Maderis Gail J Director Director Aug 12 Buy 0.7139 25,204 17,993 200,000 08/12/22
Maderis Gail J Director Director Aug 09 Buy 0.68 174,796 118,861 174,796 08/11/22
Robertson Judith J. Director Director May 26 Buy 0.3938 65,000 25,597 265,000 05/27/22
AZAB MOHAMMAD Director Director May 24 Buy 0.39 30,000 11,700 60,000 05/25/22
Farfel Gail M Director Director May 16 Buy 0.4 55,211 22,084 100,000 05/18/22
AZAB MOHAMMAD Director Director May 16 Buy 0.41 30,000 12,300 30,000 05/18/22
Farfel Gail M Director Director May 11 Buy 0.4 20,700 8,280 44,789 05/13/22
Farfel Gail M Director Director May 10 Buy 0.406 2,339 950 24,089 05/12/22
Farfel Gail M Director Director May 09 Buy 0.39 21,750 8,482 21,750 05/10/22
Joice Judy R Sr. VP Operations &.. Sr. VP Operations & Corp QA May 17 Option 0.76 60,137 45,704 94,969 05/17/21
Joice Judy R Sr. VP Operations &.. Sr. VP Operations & Corp QA May 17 Sell 1.72 60,137 103,436 34,832 05/17/21